Annual meeting
The 2023 annual meeting of stockholders took place on Wednesday, June 21, 2023 at 3:30 p.m. ET online at http://www.virtualshareholdermeeting.com/BPMC2023.
Blueprint Medicines is a fully integrated global biopharmaceutical company that invents life-changing medicines across two strategic focus areas of allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.
The 2023 annual meeting of stockholders took place on Wednesday, June 21, 2023 at 3:30 p.m. ET online at http://www.virtualshareholdermeeting.com/BPMC2023.